NYSE:ACRE - Ares Commercial Real Estate Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $15.13
Forecasted Upside: 0.43 %
Number of Analysts: 4
Breakdown:
0 Sell Ratings
1 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings

^$15.06 As of 07/23/2021 01:00 AM ET

▲ +0.16 (1.07%)

1 month | 3 months | 12 months

Get New Ares Commercial Real Estate Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ACRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACRE

^$15.13

▲ +0.43% Upside Potential

This price target is based on 4 analysts offering 12 month price targets for Ares Commercial Real Estate in the last 3 months. The average price target is $15.13, with a high forecast of $16.50 and a low forecast of $13.50. The average price target represents a 0.43% upside from the last price of $15.06.

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Ares Commercial Real Estate. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/31/2020

0 strong buy ratings
3 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/30/2020

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

7/29/2020

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/27/2020

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/25/2021

0 strong buy ratings
4 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/25/2021

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/24/2021

0 strong buy ratings
3 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

7/24/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/5/2021	Raymond James	Boost Price Target	Outperform	$15.00 ➝ $16.50	Medium
4/30/2021	BTIG Research	Reiterated Rating	Buy	$14.50	Low
4/26/2021	JPMorgan Chase & Co.	Boost Price Target	Neutral	$12.50 ➝ $13.50	Low
3/17/2021	Credit Suisse Group	Boost Price Target	Outperform	$13.00 ➝ $16.00	Low
2/25/2021	Raymond James	Boost Price Target	Outperform	$12.00 ➝ $15.00	High
2/2/2021	BTIG Research	Initiated Coverage	Buy	$13.50	Low
12/4/2020	Raymond James	Reiterated Rating	Buy	$11.00	Low
11/20/2020	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$12.00	Low
6/29/2020	Keefe, Bruyette & Woods	Upgrade	Market Perform ➝ Outperform	$10.50	Low
4/27/2020	Credit Suisse Group	Lower Price Target	Outperform	$17.50 ➝ $9.00	High
4/22/2020	JMP Securities	Lower Price Target	Market Outperform	$16.00 ➝ $10.00	High
4/13/2020	Raymond James	Lower Price Target	Strong-Buy	$16.00 ➝ $11.00	Medium
2/25/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$16.00 ➝ $16.50	High
2/21/2020	Credit Suisse Group	Boost Price Target	Outperform	$16.00 ➝ $17.50	Low
1/8/2020	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$16.00	Medium
1/11/2019	Raymond James	Upgrade	Outperform ➝ Strong-Buy		High
10/24/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$14.00 ➝ $14.50	Medium
10/8/2018	BTIG Research	Initiated Coverage	Buy ➝ Buy	$15.00	High
8/21/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$14.00 ➝ $14.50	High
7/30/2018	JMP Securities	Boost Price Target	Market Outperform ➝ Market Outperform	$14.50 ➝ $15.00	Low
7/23/2018	Raymond James	Initiated Coverage	Outperform		Low
7/23/2018	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral		Low
5/23/2018	Bank of America	Downgrade	Buy ➝ Hold	$14.00	Low
5/2/2018	Bank of America	Upgrade	Underperform ➝ Buy		High
1/9/2018	B. Riley	Reiterated Rating	Buy	$14.00	Low
11/2/2017	B. Riley	Reiterated Rating	Buy		N/A
8/17/2017	Keefe, Bruyette & Woods	Set Price Target	Hold	$14.00	Low
8/10/2017	JMP Securities	Reiterated Rating	Outperform	$15.00 ➝ $14.50	Medium
8/7/2017	JMP Securities	Boost Price Target	Market Outperform	$14.00	Low
8/4/2017	Credit Suisse Group	Reiterated Rating	Hold		High
6/9/2017	Keefe, Bruyette & Woods	Reiterated Rating	Hold	$13.75	Low
5/3/2017	Keefe, Bruyette & Woods	Reiterated Rating	Hold	$13.75	High
12/15/2016	Bank of America	Downgrade	Neutral ➝ Underperform		N/A
11/22/2016	(FBRC)	Boost Price Target	Outperform	$14.00 ➝ $14.75	N/A
11/4/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy	$14.00	N/A
9/14/2016	(FBRC)	Reiterated Rating	Buy	$13.00	N/A
9/9/2016	Credit Suisse Group	Reiterated Rating	Hold	$13.00	N/A
8/11/2016	Citigroup	Boost Price Target	Buy	$12.00 ➝ $14.00	N/A
8/8/2016	Credit Suisse Group	Reiterated Rating	Hold	$13.00	N/A
8/5/2016	Keefe, Bruyette & Woods	Boost Price Target	Market Perform	$12.00 ➝ $13.00	N/A

(Data available from 7/25/2016 forward)

Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, mezzanine loans, real estate preferred equity investments, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York.

Today's Range

Now: $15.06

$14.94

$15.12

50 Day Range

MA: $15.32

$14.44

$16.92

52 Week Range

Now: $15.06

$8.63

$16.98

Volume

245,682 shs

Average Volume

573,485 shs

Market Capitalization

$707.82 million

P/E Ratio

9.35

Dividend Yield

8.86%

Beta

1.32

Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Commercial Real Estate?

The following sell-side analysts have issued stock ratings on Ares Commercial Real Estate in the last year: BTIG Research, Credit Suisse Group AG, JPMorgan Chase & Co., Raymond James, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for ACRE.

What is the current price target for Ares Commercial Real Estate?

4 Wall Street analysts have set twelve-month price targets for Ares Commercial Real Estate in the last year. Their average twelve-month price target is $15.13, suggesting a possible upside of 0.4%. Raymond James has the highest price target set, predicting ACRE will reach $16.50 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $13.50 for Ares Commercial Real Estate in the next year.
View the latest price targets for ACRE.

What is the current consensus analyst rating for Ares Commercial Real Estate?

Ares Commercial Real Estate currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ACRE will outperform the market and that investors should add to their positions of Ares Commercial Real Estate.
View the latest ratings for ACRE.

What other companies compete with Ares Commercial Real Estate?

Other companies that are similar to Ares Commercial Real Estate include Annaly Capital Management, AGNC Investment, Starwood Property Trust, Chimera Investment, Apollo Commercial Real Estate Finance, MFA Financial, PennyMac Mortgage Investment Trust, Two Harbors Investment, New York Mortgage Trust, Redwood Trust, Ready Capital, Invesco Mortgage Capital, ARMOUR Residential REIT, Capstead Mortgage and Dynex Capital.

How do I contact Ares Commercial Real Estate's investor relations team?

Ares Commercial Real Estate's physical mailing address is 245 PARK AVENUE 42ND FLOOR, NEW YORK NY, 10167. The real estate investment trust's listed phone number is 212-750-7300 and its investor relations email address is [email protected] The official website for Ares Commercial Real Estate is www.arescre.com.